BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37644761)

  • 1. The Leu/Val
    Llinas Del Torrent C; Raïch I; Gonzalez A; Casajuana-Martin N; Lillo J; Rebassa JB; Ferreiro-Vera C; Sánchez de Medina V; Franco R; Navarro G; Pardo L
    J Chem Inf Model; 2023 Sep; 63(18):5927-5935. PubMed ID: 37644761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
    Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
    J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor.
    Zagzoog A; Brandt AL; Black T; Kim ED; Burkart R; Patel M; Jin Z; Nikolaeva M; Laprairie RB
    Sci Rep; 2021 May; 11(1):10611. PubMed ID: 34012003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB
    Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH
    Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the role of CB
    Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
    Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elucidation of partial activation of cannabinoid receptor type 2 and identification of potential partial agonists: Molecular dynamics simulation and structure-based virtual screening.
    Uba AI; Aluwala H; Liu H; Wu C
    Comput Biol Chem; 2022 Aug; 99():107723. PubMed ID: 35850049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?
    Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL
    Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
    Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
    Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of structural characteristics on the binding of synthetic cannabinoids from the JWH family to the CB1 receptor: A computational study.
    Chaturvedi K; Anthony CS; Pandey P; Doerksen RJ; Godfrey M
    J Mol Graph Model; 2024 Jan; 126():108620. PubMed ID: 37722351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
    Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
    Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid 'Spice' compounds: comparison with Δ
    Hoffman AF; Lycas MD; Kaczmarzyk JR; Spivak CE; Baumann MH; Lupica CR
    Addict Biol; 2017 Mar; 22(2):390-399. PubMed ID: 26732435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of selective cannabinoid CB
    Li X; Chang H; Bouma J; de Paus LV; Mukhopadhyay P; Paloczi J; Mustafa M; van der Horst C; Kumar SS; Wu L; Yu Y; van den Berg RJBHN; Janssen APA; Lichtman A; Liu ZJ; Pacher P; van der Stelt M; Heitman LH; Hua T
    Nat Commun; 2023 Mar; 14(1):1447. PubMed ID: 36922494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB
    Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX
    Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Tolerance and Asymmetrical Crosstolerance to Effects of the Indole Quinuclidinone Analog PNR-4-20, a G Protein-Biased Cannabinoid 1 Receptor Agonist in Mice: Comparisons with Δ
    Ford BM; Cabanlong CV; Tai S; Franks LN; Penthala NR; Crooks PA; Prather PL; Fantegrossi WE
    J Pharmacol Exp Ther; 2019 May; 369(2):259-269. PubMed ID: 30833484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor mechanisms underlying the CNS effects of cannabinoids: CB
    Hempel B; Xi ZX
    Adv Pharmacol; 2022; 93():275-333. PubMed ID: 35341569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca
    Xia KK; Shen JX; Huang ZB; Song HM; Gao M; Chen DJ; Zhang SJ; Wu J
    Acta Pharmacol Sin; 2019 Mar; 40(3):410-417. PubMed ID: 30202013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative molecular dynamics simulations of the potent synthetic classical cannabinoid ligand AMG3 in solution and at binding site of the CB1 and CB2 receptors.
    Durdagi S; Reis H; Papadopoulos MG; Mavromoustakos T
    Bioorg Med Chem; 2008 Aug; 16(15):7377-87. PubMed ID: 18595717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.